Pages that link to "Q28550703"
Jump to navigation
Jump to search
The following pages link to Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis (Q28550703):
Displayed 13 items.
- Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond (Q27826351) (← links)
- Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds. (Q30491719) (← links)
- Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules. (Q48022900) (← links)
- Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets. (Q52574425) (← links)
- Innovation in neglected tropical disease drug discovery and development. (Q55459515) (← links)
- Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis (Q56351107) (← links)
- Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis (Q58584921) (← links)
- High Throughput and Computational Repurposing for Neglected Diseases (Q60031608) (← links)
- Extracellular vesicles from Echinococcus granulosus larval stage: Isolation, characterization and uptake by dendritic cells (Q61804802) (← links)
- Histone deacetylase enzymes as potential drug targets of Neglected Tropical Diseases caused by cestodes (Q64108362) (← links)
- The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis (Q89869922) (← links)
- In vitro efficacies of solubility-improved mebendazole derivatives against Echinococcus multilocularis (Q91774760) (← links)
- Activity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells (Q93035922) (← links)